How Big Pharma Uses Authorized Generics to Game the System & Pad Profit

July 29, 2019

However, there are cases when one drug has a higher list price but lower net price than another comparable drug by the same manufacturer. Therefore, the drug with a higher list price could be more affordable for patients.

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

Other Infographics
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Read More

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

Events